Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials

Table 2 Characteristics of participants in the study

Family number	Parent interviewed	Child/young person’s age	Child/young person’s JIA status (reported by clinician)	Treatments experienced by the child/young person^b
Family number	Parent interviewed	Child/young person’s age	Child/young person’s JIA status (reported by clinician)	Tablets	IV	IM	IACI
1 ^a	Mo, Fa	11–13	Flare	✓	✓	✓	✓
2	Mo	5–7	Flare	✓			✓
3 ^a	Mo	14–16	Flare	✓	✓		✓
4^c	Mo, Fa	1–4, 5–7	Diagnosis, Flare	✓			✓
5	Mo	1–4	Diagnosis				✓
6	Mo	5–7	Diagnosis	✓			✓
7	Mo, Fa	1–4	Diagnosis				✓
8 ^a	Mo, Fa	8–10	Flare	✓			✓
9 ^a	Mo	11–13	Diagnosis		✓		✓
10 ^a	Mo	14–16	Flare	✓	✓	✓	✓
11 ^a	Mo	8–10	Flare	✓			✓
12 ^a	Mo	11–13	Diagnosis	✓	✓
13 ^a	Mo	14–16	Flare		✓		✓
14 ^a	Mo	14–16	Flare			✓	✓
15	Fa	14–16	Flare	✓	✓

Mo = Mother, Fa = Father, Tablets = Oral prednisolone, IV = Intravenous methylprednisolone, IM = Intra-muscular injection, IACI = Intra-articular injection(s). JIA status as reported by clinician
^aFamilies where the child/young person was also interviewed, ^bReported by parents, ^cFamily with two children with JIA

ISSN: 1546-0096